Spencer DI - Search Results

1

Clinical applications of phage-derived sFvs and sFv fusion proteins.

Chester KA, Bhatia J, Boxer G, Cooke SP, Flynn AA, Huhalov A, Mayer A, Pedley RB, Robson L, Sharma SK, Spencer DI, Begent RH. Chester KA, et al. Among authors: spencer di. Dis Markers. 2000;16(1-2):53-62. doi: 10.1155/2000/672706. Dis Markers. 2000. PMID: 11360829 Free PMC article. Review.

2

Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer.

Chester KA, Mayer A, Bhatia J, Robson L, Spencer DI, Cooke SP, Flynn AA, Sharma SK, Boxer G, Pedley RB, Begent RH. Chester KA, et al. Among authors: spencer di. Cancer Chemother Pharmacol. 2000;46 Suppl:S8-12. doi: 10.1007/pl00014055. Cancer Chemother Pharmacol. 2000. PMID: 10950140 Review.

3

A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex.

Cooke SP, Boxer GM, Lawrence L, Pedley RB, Spencer DI, Begent RH, Chester KA. Cooke SP, et al. Among authors: spencer di. Cancer Res. 2001 May 1;61(9):3653-9. Cancer Res. 2001. PMID: 11325835

4

A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics.

Spencer DI, Robson L, Purdy D, Whitelegg NR, Michael NP, Bhatia J, Sharma SK, Rees AR, Minton NP, Begent RH, Chester KA. Spencer DI, et al. Proteomics. 2002 Mar;2(3):271-9. doi: 10.1002/1615-9861(200203)2:3<271::aid-prot271>3.0.co;2-w. Proteomics. 2002. PMID: 11921443

5

Glycoforms obtained by expression in Pichia pastoris improve cancer targeting potential of a recombinant antibody-enzyme fusion protein.

Medzihradszky KF, Spencer DI, Sharma SK, Bhatia J, Pedley RB, Read DA, Begent RH, Chester KA. Medzihradszky KF, et al. Among authors: spencer di. Glycobiology. 2004 Jan;14(1):27-37. doi: 10.1093/glycob/cwh001. Epub 2003 Sep 26. Glycobiology. 2004. PMID: 14514711

6

Mapping antibody:antigen interactions by mass spectrometry and bioinformatics.

Huhalov A, Spencer DI, Chester KA. Huhalov A, et al. Among authors: spencer di. Methods Mol Biol. 2004;248:465-80. doi: 10.1385/1-59259-666-5:465. Methods Mol Biol. 2004. PMID: 14970514 No abstract available.

7

Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.

Hinshelwood J, Spencer DI, Edwards YJ, Perkins SJ. Hinshelwood J, et al. Among authors: spencer di. J Mol Biol. 1999 Nov 26;294(2):587-99. doi: 10.1006/jmbi.1999.3223. J Mol Biol. 1999. PMID: 10610782

8

Production and characterization of a recombinant anti-MUC1 scFv reactive with human carcinomas.

Denton G, Sekowski M, Spencer DI, Hughes OD, Murray A, Denley H, Tendler SJ, Price MR. Denton G, et al. Among authors: spencer di. Br J Cancer. 1997;76(5):614-21. doi: 10.1038/bjc.1997.434. Br J Cancer. 1997. PMID: 9303360 Free PMC article.

9

Erythropoietin N-glycosylation of Therapeutic Formulations Quantified and Characterized: An Interlab Comparability Study of High-Throughput Methods.

O'Flaherty R, Amez Martín M, Gardner RA, Jennings PM, Rudd PM, Spencer DIR, Falck D. O'Flaherty R, et al. Among authors: spencer dir. Biomolecules. 2024 Jan 18;14(1):125. doi: 10.3390/biom14010125. Biomolecules. 2024. PMID: 38254725 Free PMC article.

10

Elevated concentrations of Neu5Ac and Neu5,9Ac₂ in human plasma: potential biomarkers of cardiovascular disease.

Cheeseman J, Badia C, Elgood-Hunt G, Gardner RA, Trinh DN, Monopoli MP, Kuhnle G, Spencer DIR, Osborn HMI. Cheeseman J, et al. Among authors: spencer dir. Glycoconj J. 2023 Dec;40(6):645-654. doi: 10.1007/s10719-023-10138-3. Epub 2023 Nov 22. Glycoconj J. 2023. PMID: 37991561 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page